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Aims Cardiac hybrid imaging by fusing single-photon emission computed tomography (SPECT) myocardial perfusion
imaging with coronary computed tomography angiography (CCTA) provides important complementary diagnostic
information for coronary artery disease (CAD) assessment. We aimed at assessing the impact of cardiac hybrid





on a separate scanner forevaluation of CAD.Patients weredivided into one of the followingthree groups according to
ﬁndings in the hybrid images obtained by fusing SPECT and CCTA: (i) matched ﬁnding of stenosis by CCTA and cor-
responding reversible SPECT defect; (ii) unmatched CCTA and SPECT ﬁnding; (iii) normal ﬁnding by both CCTA and
SPECT. Follow-up was conﬁned to the ﬁrst 60 days after hybrid imaging as this allows best to assess treatment strategy
decisions including the revascularization procedure triggered by its ﬁndings. Hybrid images revealed matched,
unmatched, and normal ﬁndings in 51, 74, and 193 patients. The revascularization rate within 60 days was 41, 11,
and 0% for matched, unmatched, and normal ﬁndings, respectively (P , 0.001 for all inter-group comparisons).
Conclusion Cardiac hybrid imaging with SPECT and CCTA provides an added clinical value for decision making with regard to
treatment strategy for CAD.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
Although coronary angiography has remained the gold standard for
the diagnosis of coronary artery disease (CAD), the assessment of
functional lesion relevance cannot be based on purely morphologic
criteria. Indeed, many factors other than lumen size which cannot
be comprehensively evaluated by coronary angiography alone
determine whether or not a lesion induces myocardial ischaemia.
1
†Contributed equally.
* Corresponding author. Tel: +41 44 255 4196, Fax: +41 44 255 4414, Email: pak@usz.ch
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2011. For permissions please email: journals.permissions@oup.com.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article
for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the
original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this
must be clearly indicated. For commercial re-use, please contact journals.permissions@oup.com
European Heart Journal (2011) 32, 2824–2829
doi:10.1093/eurheartj/ehr232Nevertheless, in clinical practice, a luminal narrowing greater than
50% is widely used as a cut-off to deﬁne the presence of relevant
CAD. For prognostically relevant target vessel revascularization
comprehensive evaluation including proof of ischaemia is manda-
tory, because interventions on non-ﬂow limiting stenoses confer
no prognostic or symptomatic beneﬁt to the patients, but are
still associated with the risk of the intervention.
2,3 As a conse-
quence, non-invasive functional assessment with single-photon
emission computed tomography (SPECT) myocardial perfusion
imaging (MPI) has been suggested as gatekeeper for coronary
angiography.
4,5 Up until recently, complimentary information on
coronary artery anatomy and the degree and site of myocardial
ischaemia has been integrated mentally by combining the infor-
mation obtained from invasive coronary angiography and
SPECT-MPI, respectively. Unfortunately, however, standard myo-
cardial distribution territories correspond in only 50–60% to the
real anatomic tree.
6 Although several attempts of software-based
hybrid imaging integrating invasive coronary angiography and
SPECT have been made to better match the coronary arteries
with the corresponding perfused myocardial territories, this was
not widely implemented into clinical practice, as its invasiveness
does not allow pre-interventional non-invasive decision
making.
6–9 With the introduction of coronary computed tomogra-
phy angiography (CCTA), a non-invasive method for accurate visu-
alization of coronary anatomy is now available.
10 This has paved
the way for purely non-invasive SPECT/CT hybrid imaging,
11
directly relating individual myocardial perfusion territories to the
subtending coronary artery. Although the integration of SPECT
or PET devices with multislice CT scanners into hybrid devices
has increased the interest in cardiac fusion imaging
12,13 and
recent results conﬁrm its diagnostic strengths,
14,15 the added clini-
cal value of cardiac hybrid imaging in the decision making for treat-
ment strategy selection has not yet been documented. The aim of
the present study was to evaluate the impact of fused SPECT and




We included 318 consecutive patients who were referred for the
evaluation of known or suspected CAD by SPECT-MPI and CCTA
within 1+3 days. The results of the fused SPECT-MPI and CCTA
images were reported to the referring physician who took into
account the hybrid imaging test result, as well as the clinical history
and the symptoms to make a decision towards invasive coronary
angiography or conservative management. Patients were followed for
revascularization procedures, including percutaneous coronary inter-
vention (PCI) and coronary artery bypass graft surgery (CABG) after
completing cardiac hybrid imaging. Follow-up was conﬁned to the
ﬁrst 60 days after hybrid imaging as this allows best to assess the treat-
ment strategy decisions including the revascularization procedure
directly triggered by its ﬁndings, while later interventions are not
directly triggered by the hybrid imaging results but rather reﬂect
events of the natural course of the disease process. The study protocol
was approved by the institutional review board (local ethics commit-
tee) and written informed consent was obtained from each patient
before enrolment. The study population was in part shared with the
recently reported registry on long-term outcome prediction by
hybrid SPECT/CT imaging.
16 The pre-test likelihood of CAD was
determined using the Diamond and Forrester method, with a risk
threshold of ,13.4% for low risk, between 13.4 and 87.2% for inter-
mediate risk, and .87.2% for high risk, as previously reported.
17
Hybrid imaging
All patients underwent a 1-day stress/rest SPECT-MPI protocol with
standard adenosine stress (0.14 mg/kg/min over 6 min)
18 on a dual-
head gamma camera (Millenium VG and Hawkeye or Ventri, both
GE Healthcare, Milwaukee, Wisconsin) as previously reported.
19 On
a stand-alone 64-slice CT scanner (LightSpeed VCT, GE Healthcare),
a low-dose CT was performed for attenuation correction of
SPECT-MPI.
20 In addition, all patients underwent contrast-enhanced
CCTA with helical scanning (n ¼ 248) or prospective ECG triggering
(n ¼ 70) as previously described in detail.
21–23 In order to achieve a
target heart rate ,65 bpm, intravenous metoprolol (5–20 mg) was
administered prior to the CCTA examination if necessary. Patients
with atrial ﬁbrillation were not referred for CCTA. Furthermore, all
patients received 2.5 mg sublingual isosorbiddinitrate 2 min prior to
the scan.
Images from SPECT-MPI and CCTA were fused on a dedicated
workstation (Advantage Workstation 4.3, GE Healthcare) using the
CardIQ Fusion software package (GE Healthcare) as previously
described in detail.
24 Brieﬂy, an optimized alignment tool allows pro-
jection of the SPECT image on the left ventricular epicardial surface
obtained from the CCTA. The 3D volume rendered fusion images
allow a panoramic view of the coronary artery tree projected onto
the left ventricular myocardial perfusion territories. Then images can
be displayed in freely selectable angles and displayed in standard
anterior, posterior, lateral, and apical view for standardized documen-
tation and reporting (Figure 1). Radiation dose for SPECT-MPI was cal-
culated as
99mTc-tetrofosmin activity times 7.9 mSv/GBq, while
effective radiation dose for CCTA was estimated as dose-length
product times a conversion coefﬁcient for the chest k ¼ 0.014 mSv/
(mGy.cm).
Hybrid image interpretation
Two experienced nuclear cardiologists analysed the fused SPECT and
CCTA images by consensus with regard to functionally relevant coron-
ary stenoses. For each patient, myocardial tomograms were divided
into 20 segments. Following 5-point system was used to score the seg-
ments: 0 ¼ normal, 1 ¼ equivocal, 2 ¼ moderate, 3 ¼ severe
reduction of radioisotope uptake, 4 ¼ absence of detectable tracer
in a segment. An abnormal scan was deﬁned as one in which two or
more segments had stress scores ≥2. A scan was classiﬁed as revers-
ible perfusion defect if a stress defect was associated with a rest score
≤1 or a stress defect score of 4 with a rest score of 2. As ischaemia-
driven patient management is most evidence-based only reversible
defects were considered for further analysis.
A matched SPECT/CT hybrid imaging ﬁnding was deﬁned as a
reversible SPECT-MPI defect in a territory subtended by a stenotic
coronary artery (deﬁned as narrowing of the coronary luminal diam-
eter ≥50%). All other combinations of pathologic ﬁndings were classi-
ﬁed as unmatched. Consequently, in order to assess the clinical value
of hybrid images on decision making for treatment strategy selection,
all patients were assigned to one of the following three categories of
ﬁndings: (i) matched: CCTA and matched (reversible) SPECT ﬁndings
as deﬁned above; (ii) unmatched: any unmatched pathologic ﬁnding
from CCTA and/or SPECT; (iii) normal: no pathologic ﬁnding, i.e. no
stenosis by CCTA and no (ﬁxed or reversible) defect by SPECT.
Cardiac hybrid imaging: treatment strategy 2825Statistical analysis
SPSS software (SPSS 15.0, SPSS Inc.) was used for statistical testing.
Quantitative variables were expressed as mean+standard deviation
and categorical variables as frequencies or percentages. The
Chi-square test was used to compare the revascularization rates
between the different patient groups. P-values from two-sided tests
of less than 0.05 were considered statistically signiﬁcant.
Results
Patient characteristics
Coronary computed tomography angiography and SPECT were
successfully performed in 318 patients. Baseline characteristics of
the study population are given in Table 1.
Single-photon emission computed
tomography and coronary computed
tomography angiography ﬁndings
Single-photon emission computed tomography revealed normal
perfusion in 248 patients (78%) and an abnormal perfusion in 70
patients (22%). A normal CCTA examination was observed in
209 patients (66%), while CCTA identiﬁed a signiﬁcant stenosis
in 109 patients (34%). Matched pathologic hybrid ﬁndings (CCTA
stenosis with corresponding reversible MPI defect) were observed
in 51 patients (16%). Unmatched ﬁndings were present in 74
patients (23%), while the remaining patients were normal by
both imaging methods (n ¼ 193, 61%).
The effective radiation dose for stress/rest SPECT-MPI was
10.1+0.9 mSv, while the estimated radiation dose for the
CCTA was 17.9+5.8 mSv when helical scanning was used (n ¼
248). After introducing prospective triggering for CCTA, the effec-
tive radiation dose was systematically recorded and resulted in
1.9+0.5 mSv (n ¼ 70).
Impact on patient management
During follow-up, of the patients with matched ﬁndings (n ¼ 51)
by hybrid cardiac imaging, 31 (61%) were further evaluated by inva-
sive coronary angiography of whom 21 underwent a revasculariza-
tion procedure (PCI: n ¼ 20; CABG: n ¼ 1), thus resulting in a
revascularization rate of 41%. In 15 of the 20 patients not
further evaluated by invasive angiography, the reason for not
being referred to invasive angiography was the limited extent of
the ischaemia, which was signiﬁcantly smaller (2.7+5.0%) than
in those patients referred to angiography (9.0+9.1%, P ,
0.001). In the remaining ﬁve patients, other reasons for conserva-
tive decision were observed such as for example difﬁcult lesion
accessibility.
In the patient group with unmatched ﬁndings (n ¼ 74), 15 (20%)
underwent invasive coronary angiography, of whom in 8 patients




Table 1 Baseline characteristics
n 318
Age (years) 61+11
Males, n (%) 213 (67)





Positive family history 87 (27)
Reason referral, n (%)
Pre-operative evaluation, equivocal/abnormal stress test 122 (38)
Non-anginal chest pain 58 (18)
Atypical angina 60 (20)
Typical angina 46 (14)
Dyspnoea 32 (10)




Known CAD, n (%) 68 (21)
Previous MI 19 (6)
CAD, coronary artery disease; MI, myocardial infarction. Figure 1 Matched hybrid ﬁnding in single-photon emission
computed tomography/computed tomography showing in the
posterior (A) and anterior (B) view an ischaemia of the apex
(arrowheads) in a territory subtended by a stenotic LAD
(arrow) as further documented in the multiplanar coronary com-
puted tomography angiography reconstruction (C).
A.P. Pazhenkottil et al. 2826resulted in a revascularization rate of 11% which was substantially
lower than in the group with matched ﬁndings (i.e. 41%; P ,
0.001). In contrast, in the normal group, no invasive coronary
angiography was performed (Figure 2).
Of note, in the matched groups, the yield of CAD per angiogra-
phy was 90% with a PCI rate per angiography of 68%, compared
with 80% and 53% in the unmatched group.
Discussion
The present study shows that cardiac hybrid imaging with fused
SPECT/CT images provides an added clinical value in the decision-
making process leading to adequate treatment strategy.
Despite the fact that invasive coronary angiography is costly and
associated with a small, but signiﬁcant rate of procedural and in
hospital morbidity and mortality,
25,26 so far, invasive coronary
angiography has remained the gold standard for the detection of
CAD and decision-making for or against a revascularization pro-
cedure. Nevertheless, it has been suggested that for best clinical
practice, myocardial perfusion should also be assessed in addition
to the anatomical information provided by angiography. Indeed,
only under these conditions may an appropriate and evidence-
based clinical decision-making process ensue. This has been
recently conﬁrmed by the prospective randomized FAME trial
using coronary pressure measurements during angiography.
2 Myo-
cardial perfusion imaging with SPECT is a well-established
non-invasive method for the assessment of myocardial ischaemia.
A recently introduced non-invasive method for assessing coronary
anatomy is CCTA. Although CCTA is accurate and helpful in risk
stratiﬁcation,
10,27 it has been recognized that CCTA alone may
not replace conventional invasive CA as it essentially also only pro-
vides anatomical information. However, the latest advance in non-
invasive cardiac imaging allows to obtain hybrid images from separ-
ately acquired CCTA and SPECT-MPI images.
28 This has been
shown to be helpful in clinical routine, as it allows non-invasive
and comprehensive assessment of CAD based on anatomical and
functional information and thus may contribute to avoid unnecess-
ary invasive angiographies.
5 A previous study documented that
hybrid imaging may indeed provide added diagnostic information.
28
However, that study evaluated patients already selected for inva-
sive coronary angiography. Thus, it remained unclear whether
and how the ﬁndings obtained by hybrid imaging may have
impacted on the clinical decision process. Moreover, that study
used ﬁxed and reversible defects on hybrid images to assess the
clinical value of hybrid imaging. In contrast, the current study
used only reversible defects because ischaemia in territories sub-
tended by stenotic coronaries constitutes the primary indication
for revascularization, while scar tissue does not. This may have
contributed to the fact that hybrid ﬁndings had a major impact
on clinical decision making in patients evaluated for CAD. The sub-
stantial difference in intervention frequencies between matched
and unmatched ﬁndings reﬂects the difﬁculty in determining the
appropriate therapy for patients with chronic stable CAD as, for
example, seen in the COURAGE trial.
29 This is further evidenced
by the fact that even in the group with matched ﬁndings, not all
lesions were revascularized as optimal medical treatment offers
an excellent alternative in many patients. Hybrid imaging provides
a solid ground on which decision making towards revascularization
can be based. The correct identiﬁcation of patients who qualify for
invasive coronary angiography and potentially for intervention by
hybrid imaging may help saving the cost and the risk of unnecessary
diagnostic angiography and ineffective revascularization. In fact, the
yield of CAD by invasive angiography after initial evaluation by
hybrid imaging was 90%, comparing favourably with the low yield
of 39% recently reported in a large registry of elective diagnostic
angiographies.
30 Consequently, the improved non-invasive evalu-
ation by hybrid imaging increased the intervention rate per diag-
nostic angiography to 68% in the group with matched ﬁndings, a
proportion which is substantially higher than ﬁgures reported in
registries of most European countries. For example, in the
German registry, a PCI or a bypass was only performed in 36%
of the patients undergoing an elective invasive angiography.
31
We acknowledge the following limitations to our study:
Although patients were included consecutively, there was no ran-
domization to different treatment strategies as in this prospective
observational study the impact of cardiac hybrid imaging on clinical
decision-making in daily clinical routine was assessed. Further pro-
spective clinical studies are necessary to deﬁne whether this hybrid
SPECT/CT-guided approach has a positive effect on long-term
outcome. In parallel, this would offer an assessment of cost efﬁ-
cacy. From the present data, we cannot prove that without non-
invasive imaging, all patients would have been referred for invasive
angiography. Nevertheless, the fact that 90% of the present study
population represent an intermediate to high-risk population
seems to support the notion that in 80% of the patients of the
present study with unmatched ﬁndings an invasive angiography
was avoided, although no data on the clinical beneﬁt were
obtained. Finally, the additive radiation burden from combined
nuclear and CT scanning is a limitation of this approach as values
of up to 41 mSv have been initially reported.
32 However, the
mean radiation dose in the ﬁrst 248 patients was substantially
lower, namely 28 mSv. Furthermore, radiation dose can be
reduced signiﬁcantly by implementing dose reduction techniques
for SPECT
33–35 and by using prospective ECG-triggering for
CCTA.
22,23,36 Of note, the latter has been used for the last 70
patients in the present study, resulting in an effective radiation
Figure 2 The frequency of revascularization was signiﬁcantly
different among the three patient groups, i.e. that with normal,
unmatched, and matched hybrid ﬁndings (P , 0.001 by
Chi-square test).
Cardiac hybrid imaging: treatment strategy 2827dose of 1.9+0.5 mSv for CCTA reducing the cumulative effective
dose of the entire SPECT/CT study to 12 mSv. Combining opti-
mized SPECT and CT will allow to reach values below 5 mSv
34
and in optimal cases below 3 mSv for such hybrid examinations.
37
Thus, in summary, cardiac hybrid imaging with SPECT and
CCTA is a feasible tool providing an added clinical value for
decision making with regard to treatment strategy for CAD.
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